RedChip Companies
|
Weekly Newsletter
|
|
Rail Vision Launches Proof-of-Concept Pilot Program of AI Obstacle Detection Technology with Leading US-Based Rail & Leasing Services Company
|
Rail Vision (Nasdaq: RVSN), a technology company that is seeking to revolutionize railway safety and the data-related market, announced that a leading US-based rail and leasing services company purchased a Rail Vision Switch Yard System to evaluate its performance during a six-month trial. Rail Vision’s unique Switch Yard System combines advanced vision sensors with artificial intelligence and deep learning technologies to streamline and enhance the safety of shunting operations.
For more information, visit www.railvision.io
|
Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering
Bullfrog AI (Nasdaq: BFRG), a digital technology company using machine learning to usher in a new era of precision medicine, announced the closing of its initial public offering, which raised $8.4 million in gross proceeds.
|
Permex Petroleum Issues Shareholder Letter and Provides Corporate Update
Permex Petroleum (OTCQB: OILCF), an independent energy company engaged in the acquisition, exploration, development, and production of oil and natural gas properties on private, state and federal land in the United States, issued a letter to shareholders from its President & CEO, Mehran Ehsan.
|
|
|
Sidus Space Announces Multi-Million-Dollar Agreement with Netherlands for Laser Communication Satellite
Sidus Space (Nasdaq: SIDU), a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and space-based data collection combined with space and defense mission critical hardware manufacturing, has been awarded a multi-million dollar agreement with The Netherlands Organization for Applied Scientific Research (TNO) to deploy and test TNO's laser communications technology aboard a Sidus' LizzieSat™ satellite.
|
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
Inspira Technologies (Nasdaq: IINN), a company creating new acute respiratory care technologies, received approval from the Ethics Committee at Sheba Medical Center in Israel to conduct a clinical study of the Company’s HYLA blood sensor in patients undergoing open-heart surgery. The study is planned to commence in the first quarter of 2023.
|
|
|
Upcoming Events |
|
|
|
OTCQB: AMNI - American Noble Gas |
11:00am Eastern |
American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: DGLY - Digital Ally |
11:00am Eastern |
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
11:00am Eastern |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
11:00am Eastern |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. |
|
|
|
|
NASDAQ: IMNM - Immunome |
4:15pm Eastern |
Immunome was founded to advance the discovery and development of antibody-based drugs. Our proprietary antibody Discovery Engine identifies novel therapeutic antibodies, and their antigen targets, by leveraging the most highly-educated components of the B cells from patients who have learned to fight off their disease. |
|
|
|
|
NASDAQ: BIVI - BioVie |
4:15pm Eastern |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: APM - Aptorum Group |
4:15pm Eastern |
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs. |
|
|
Archive Events |
|
|
|
NYSE American: GNS - Genius Group |
Meeting Duration 74 minutes |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: KWE - KWESST Micro Systems |
Meeting Duration 38 minutes |
KWESST Micro Systems develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 28 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
Meeting Duration 62 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 46 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
Meeting Duration 37 minutes |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. |
|
|
|
|
NASDAQ: RVPH - Reviva Pharmaceutical |
Meeting Duration 46 minutes |
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. |
|
|
|
|
NASDAQ: SIDU - Sidus Space |
Meeting Duration 19 minutes |
Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals 2023 KOL Events |
Meeting Duration 60 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
OTCQB: OILCF - Permex Petroleum Corp |
Meeting Duration 40 minutes |
Permex Petroleum is a uniquely positioned junior Oil & Gas company with assets and operations across the Permian Basin of west Texas and the Delaware Sub-Basin of New Mexico. |
|
|
Lesson of the Week
The value of dollar-cost averaging.
|
|
|
MidSouth Week in Review
The average U.S. mortgage rate jumped to 6.32%, the highest level in five weeks.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|